The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2019

Filed:

Jun. 07, 2016
Applicants:

Tania VU, Portland, OR (US);

Thomas Jacob, Beaverton, OR (US);

Brian J Druker, Portland, OR (US);

Inventors:

Tania Vu, Portland, OR (US);

Thomas Jacob, Beaverton, OR (US);

Brian J Druker, Portland, OR (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 31/00 (2006.01); G01N 33/58 (2006.01); G01N 33/68 (2006.01); G01N 33/574 (2006.01); B82Y 15/00 (2011.01);
U.S. Cl.
CPC ...
G01N 33/588 (2013.01); G01N 33/57426 (2013.01); G01N 33/57484 (2013.01); G01N 33/57496 (2013.01); G01N 33/587 (2013.01); G01N 33/6842 (2013.01); B82Y 15/00 (2013.01); G01N 2333/47 (2013.01); G01N 2440/14 (2013.01); G01N 2500/20 (2013.01); G01N 2800/52 (2013.01);
Abstract

Embodiments herein provide methods, apparatuses, and systems for detecting, monitoring, measuring, and/or characterizing the activity of phosphoproteins such as tyrosine kinases (TKs) and downstream proteins in TK signal transduction pathways (e.g., TK pathway proteins). In various embodiments, the methods, apparatuses, and systems may use nanoparticles, such as quantum dots (QD), to detect and/or characterize the abnormally overactive TK signaling pathways that underlie tumorgenesis and tumor progression. In various embodiments, the QD-based methods, apparatuses, and systems may have a sufficiently high degree of sensitivity to enable the identification of new TK signaling pathway markers, for example for use in diagnosing, staging, monitoring, and/or prognosing cancers, or in evaluating the efficacy of cancer therapeutics.


Find Patent Forward Citations

Loading…